Why the study?
Does gadolinium prevent ischemia-induced QTI shortening, ST elevation, and arrhythmias in a canine model of acute coronary occlusion?
Does gadolinium prevent ischemia-induced QTI shortening, ST elevation, and arrhythmias in a canine model of acute coronary occlusion?
Activation of stretch-activated channels due to local wall motion abnormalities immediately after acute coronary occlusion contributes to QTI shortening, ST elevation, and arrhythmogenesis independently of KATP channels.
Gadolinium effects in canine ischemia do not inform clinical care; leaves open human studies on ECG changes during occlusion.
No takes yet. Share an insight, caveat, or question.
Takagi et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: